相似文献
1
Deletions in BCP-ALL result in a TAD more FLT3.
Blood. 2020 Aug 20;136(8):919-920. doi: 10.1182/blood.2020006607.
2
13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking.
Blood. 2020 Aug 20;136(8):946-956. doi: 10.1182/blood.2019004684.
3
[FLT3 mutation in patients with acute lymphoblastic leukemia and its clinical significance].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2009 Oct;31(5):522-6.
4
D-HPLC analysis of the entire FLT3 gene in MLL rearranged and hyperdiploid acute lymphoblastic leukemia.
Haematologica. 2007 Nov;92(11):1565-8. doi: 10.3324/haematol.11220.
5
The role of constitutive activation of FMS-related tyrosine kinase-3 and mutational status in infants with -rearranged acute lymphoblastic leukemia.
Haematologica. 2017 Nov;102(11):e438-e442. doi: 10.3324/haematol.2017.169870. Epub 2017 Aug 24.
6
FLT3 mutations in patients with childhood acute lymphoblastic leukemia (ALL).
Med Oncol. 2013 Mar;30(1):462. doi: 10.1007/s12032-013-0462-6. Epub 2013 Jan 19.
7
FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia.
Pharmacol Res. 2020 Jan;151:104556. doi: 10.1016/j.phrs.2019.104556. Epub 2019 Nov 25.
8
Prognostic significance of high-level FLT3 expression in MLL-rearranged infant acute lymphoblastic leukemia.
Blood. 2007 Oct 1;110(7):2774-5. doi: 10.1182/blood-2007-05-091934.
9
Hidden FLT3-D835Y clone in FLT3-ITD-positive acute myeloid leukemia that evolved into very late relapse with T-lymphoblastic leukemia.
Leuk Lymphoma. 2018 Jun;59(6):1490-1493. doi: 10.1080/10428194.2017.1382696. Epub 2017 Oct 3.
10
Detection of FLT3 gene and FLT3/ITD mutation by polymerase chain reaction-single-strand conformation polymorphism in patients with acute lymphoblastic leukemia.
Di Yi Jun Yi Da Xue Xue Bao. 2005 Oct;25(10):1207-10.
引用本文的文献
1
13q12.2 deletions and FLT3 overexpression in acute leukemias.
Blood Adv. 2021 Apr 27;5(8):2075-2078. doi: 10.1182/bloodadvances.2020003643.
本文引用的文献
1
13q12.2 deletions in acute lymphoblastic leukemia lead to upregulation of FLT3 through enhancer hijacking.
Blood. 2020 Aug 20;136(8):946-956. doi: 10.1182/blood.2019004684.
2
Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent and enhancer hijacking in primary gastric adenocarcinoma.
Gut. 2020 Jun;69(6):1039-1052. doi: 10.1136/gutjnl-2018-317612. Epub 2019 Sep 21.
3
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation.
N Engl J Med. 2017 Aug 3;377(5):454-464. doi: 10.1056/NEJMoa1614359. Epub 2017 Jun 23.
4
Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.
Nat Genet. 2017 Jan;49(1):65-74. doi: 10.1038/ng.3722. Epub 2016 Nov 21.
5
The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia.
Nat Genet. 2015 Jun;47(6):672-6. doi: 10.1038/ng.3301. Epub 2015 May 11.
6
Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.
Science. 2014 Dec 12;346(6215):1373-7. doi: 10.1126/science.1259037. Epub 2014 Nov 13.
7
A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia.
Cell. 2014 Apr 10;157(2):369-381. doi: 10.1016/j.cell.2014.02.019. Epub 2014 Apr 3.
8
Highly recurrent TERT promoter mutations in human melanoma.
Science. 2013 Feb 22;339(6122):957-9. doi: 10.1126/science.1229259. Epub 2013 Jan 24.
9
TERT promoter mutations in familial and sporadic melanoma.
Science. 2013 Feb 22;339(6122):959-61. doi: 10.1126/science.1230062. Epub 2013 Jan 24.
10
Mechanisms of B-cell lymphoma pathogenesis.
Nat Rev Cancer. 2005 Apr;5(4):251-62. doi: 10.1038/nrc1589.
Zotero 插件